Cargando…
In Silico Screening of Drugs That Target Different Forms of E Protein for Potential Treatment of COVID-19
Recently the E protein of SARS-CoV-2 has become a very important target in the potential treatment of COVID-19 since it is known to regulate different stages of the viral cycle. There is biochemical evidence that E protein exists in two forms, as monomer and homopentamer. An in silico screening anal...
Autores principales: | Ramírez Salinas, Gema Lizbeth, López Rincón, Alejandro, García Machorro, Jazmín, Correa Basurto, José, Martínez Archundia, Marlet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958997/ https://www.ncbi.nlm.nih.gov/pubmed/37259437 http://dx.doi.org/10.3390/ph16020296 |
Ejemplares similares
-
Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study
por: Ramírez-Salinas, Gema Lizbeth, et al.
Publicado: (2020) -
The Advantage of Using Immunoinformatic Tools on Vaccine Design and Development for Coronavirus
por: García-Machorro, Jazmín, et al.
Publicado: (2022) -
In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking
por: Vázquez-Mendoza, Luis Heriberto, et al.
Publicado: (2022) -
Inhibition of Influenza A Virus Infection In Vitro by Peptides Designed In Silico
por: López-Martínez, Rogelio, et al.
Publicado: (2013) -
Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide by molecular dynamics simulations
por: Chi, L. América, et al.
Publicado: (2022)